Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
33.47
-0.30 (-0.89%)
Jul 28, 2026, 3:20 PM EDT - Market open
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.7 billion as of July 28, 2026. Its market cap has decreased by -3.64% in one year.
Market Cap
1.70B
Enterprise Value
1.28B
1-Year Change
-3.64%
Ranking
Category
Stock Price
$33.47
ChartMarket Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from $1.80B to $1.70B, a decrease of -5.20%. That is a compound annual growth rate of -0.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 1.70B | -2.93% |
| Dec 31, 2025 | 1.75B | 18.83% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | -16.41% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stoke Therapeutics | 1.85B |
| Lakefront Biotherapeutics NV | 1.84B |
| Damora Therapeutics | 1.83B |
| Fortrea Holdings | 1.82B |
| Taysha Gene Therapies | 1.81B |
| Generate Biomedicines | 1.76B |
| Maravai LifeSciences Holdings | 1.74B |
| Sarepta Therapeutics | 1.72B |